112 related articles for article (PubMed ID: 30583247)
1. New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases.
Martín-Escolano R; Molina-Carreño D; Delgado-Pinar E; Martin-Montes Á; Clares MP; Medina-Carmona E; Pitarch-Jarque J; Martín-Escolano J; Rosales MJ; García-España E; Sánchez-Moreno M; Marín C
Eur J Med Chem; 2019 Feb; 164():27-46. PubMed ID: 30583247
[TBL] [Abstract][Full Text] [Related]
2. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
[TBL] [Abstract][Full Text] [Related]
4. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease.
Sánchez-Moreno M; Marín C; Navarro P; Lamarque L; García-España E; Miranda C; Huertas O; Olmo F; Gómez-Contreras F; Pitarch J; Arrebola F
J Med Chem; 2012 May; 55(9):4231-43. PubMed ID: 22443115
[TBL] [Abstract][Full Text] [Related]
7. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.
Alberca LN; Sbaraglini ML; Balcazar D; Fraccaroli L; Carrillo C; Medeiros A; Benitez D; Comini M; Talevi A
J Comput Aided Mol Des; 2016 Apr; 30(4):305-21. PubMed ID: 26891837
[TBL] [Abstract][Full Text] [Related]
9. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
[TBL] [Abstract][Full Text] [Related]
10. Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.
Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM
Antimicrob Agents Chemother; 2015 Aug; 59(8):4653-61. PubMed ID: 26014936
[TBL] [Abstract][Full Text] [Related]
11. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
[TBL] [Abstract][Full Text] [Related]
12. Novel nitroimidazoles with trypanocidal and cell growth inhibition activities.
Boechat N; Carvalho AS; Fernandez-Ferreira E; Soares RO; Souza AS; Gibaldi D; Bozza M; Pinto AC
Cytobios; 2001; 105(409):83-90. PubMed ID: 11393774
[TBL] [Abstract][Full Text] [Related]
13. In vitro investigation of the efficacy of novel diamidines against Trypanosoma cruzi.
Timm BL; Da Silva PB; Batista MM; Farahat AA; Kumar A; Boykin DW; Soeiro MN
Parasitology; 2014 Sep; 141(10):1272-6. PubMed ID: 24735493
[TBL] [Abstract][Full Text] [Related]
14. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.
Campos-Estrada C; Liempi A; González-Herrera F; Lapier M; Kemmerling U; Pesce B; Ferreira J; López-Muñoz R; Maya JD
PLoS Negl Trop Dis; 2015 May; 9(5):e0003770. PubMed ID: 25978361
[TBL] [Abstract][Full Text] [Related]
16. Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment.
Aguilera E; Varela J; Serna E; Torres S; Yaluff G; Bilbao NV; Cerecetto H; Alvarez G; González M
Mem Inst Oswaldo Cruz; 2018 Mar; 113(3):153-160. PubMed ID: 29412353
[TBL] [Abstract][Full Text] [Related]
17. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB/c mouse model.
Martín-Escolano R; Marín C; Vega M; Martin-Montes Á; Medina-Carmona E; López C; Rotger C; Costa A; Sánchez-Moreno M
Bioorg Med Chem; 2019 Mar; 27(5):865-879. PubMed ID: 30728107
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
Villarreal D; Barnabé C; Sereno D; Tibayrenc M
Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo identification of tetradentated polyamine complexes as highly efficient metallodrugs against Trypanosoma cruzi.
Olmo F; Cussó O; Marín C; Rosales MJ; Urbanová K; Krauth-Siegel RL; Costas M; Ribas X; Sánchez-Moreno M
Exp Parasitol; 2016 May; 164():20-30. PubMed ID: 26874306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
